Top

Published in:

01-10-2019 | Public Health | Original Paper

Leveraging the strength of comprehensive cancer control coalitions to support policy, systems, and environmental change

Authors: Angela Moore, Aubrey Villalobos, Annette L. Gardner, Citseko Staples, Sarah Shafir

Published in: Cancer Causes & Control | Issue 10/2019

Abstract

Strategies that facilitate change to policy, systems, and environmental (PSE) changes can enable behaviors and practices that lead to cancer risk reduction, early detection, treatment access, and improved quality of life among survivors. Comprehensive cancer control is a coordinated collaborative approach to reduce cancer burden and operationalizes PSE change strategies for this purpose. Efforts to support these actions occur at the national, state, and local levels. Resources integral to bolstering strategies for sustainable cancer control include coordination and support from national organizations committed to addressing the burden of cancer, strong partnerships at the state and local levels, funding and resources, an evidence-based framework and program guidance, and technical assistance and training opportunities to build capacity. The purpose of this paper is to describe the impact of public policy, public health programming, and technical assistance and training on the use of PSE change interventions in cancer control. It also describes the foundations for and examples of successes achieved by comprehensive cancer control programs and coalitions using PSE strategies.

Given LS, Black B, Lowry G, Huang P, Kerner JF (2005) Collaborating to conquer cancer: a comprehensive approach to cancer control. Cancer Causes Control 16(Suppl 1):3–14. https://doi.org/10.1007/s10552-005-0499-8 CrossRefPubMed

Centers for Disease Control and Prevention (2017) About the National Comprehensive Cancer Control Program. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention. https://www.cdc.gov/cancer/ncccp/about.htm. Accessed 21 Sept 2018

Stewart S HN, Moore A, Bailey R, Brown P, Wanliss E (2019) Combating cancer through public health practice in the United States: an in-depth look at the National Comprehensive Cancer Control Program. In: Majumder AA (ed) Public Health. Intech Open, London

Selig WK, Jenkins KL, Reynolds SL, Benson D, Daven M (2005) Examining advocacy and comprehensive cancer control. Cancer Causes Control 16(1):61–68. https://doi.org/10.1007/s10552-005-0485-1 CrossRefPubMed

Steger C, Daniel K, Gurian GL, Petherick JT, Stockmyer C, David AM, Miller SE (2010) Public policy action and CCC implementation: benefits and hurdles. Cancer Causes Control 21(12):2041–2048. https://doi.org/10.1007/s10552-010-9668-5 CrossRefPubMedPubMedCentral

Bauer UE, Briss PA, Goodman RA, Bowman BA (2014) Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet 384(9937):45–52. https://doi.org/10.1016/S0140-6736(14)60648-6 CrossRefPubMed

Frieden TR (2010) A framework for public health action: the health impact pyramid. Am J Public Health 100(4):590–595. https://doi.org/10.2105/AJPH.2009.185652 CrossRefPubMedPubMedCentral

Studlar D (2014) Cancer prevention through stealth: science, policy advocacy, and multilevel governance in the establishment of a "National Tobacco Control Regime" in the United States. J Health Polit Policy Law 39(3):503–535CrossRefPubMed

Rohan EA, Chovnick G, Rose J, Townsend JS, Young M, Moore AR (2018) Prioritizing population approaches in cancer prevention and control: results of a case study evaluation of policy, systems, and environmental change. Popul Health Manag 22(3):205–212. https://doi.org/10.1089/pop.2018.0081 CrossRefPubMedPubMedCentral

10.

Townsend JS, Sitaker M, Rose J, Rohan E, Gardner A, Moore A (2019) Capacity building for the implementation of policy, systems, and environmental change: results from a survey of the National Comprehensive Cancer Control Program. Popul Health Manag 22(4):330–338CrossRefPubMed

11.

Gardner A, Geierstanger S, Miller Nascimento L, Brindis C (2011) Expanding organizational advocacy capacity: reflections from the field. Foundation Rev 3(1):4CrossRef

12.

Chin JJ, Abesamis-Mendoza N (2012) Project CHARGE: building an urban health policy advocacy community. Prog Commun Health Partnersh 6(1):17–23. https://doi.org/10.1353/cpr.2012.0004 CrossRef

13.

Comprehensive Cancer Control National Partnership (2016) About us: the mission of the Comprehensive Cancer Control National Partnership. https://www.cccnationalpartners.org/about-us. Accessed 29 June 2018

14.

Hefelfinger J, Patty A, Ussery A, Young W (2013) Technical assistance from state health departments for communities engaged in policy, systems, and environmental change: the ACHIEVE Program. Prev Chronic Dis 10:E175. https://doi.org/10.5888/pcd10.130093 CrossRefPubMedPubMedCentral

15.

Leeman J, Calancie L, Hartman MA, Escoffery CT, Herrmann AK, Tague LE, Moore AA, Wilson KM, Schreiner M, Samuel-Hodge C (2015) What strategies are used to build practitioners’ capacity to implement community-based interventions and are they effective?: a systematic review. Implementation Science 10(1):80CrossRef

16.

Centers for Disease Control and Prevention (2013) CDC-RFA-DP13–1315: National support to enhance implementation of Comprehensive Cancer Control activities.

17.

Centers for Disease Control and Prevention (2017) CDC-RFA-DP17–1701: Cancer prevention and control programs for state, territorial, and tribal organizations.

18.

Centers for Disease Control and Prevention (2010) CDC-RFA-DP10–1017 Demonstrating the capacity of Comprehensive Cancer Control Programs to implement policy and environmental cancer control interventions.

19.

Brownson RC, Dodson EA, Stamatakis KA, Casey CM, Elliott MB, Luke DA, Wintrode CG, Kreuter MW (2011) Communicating evidence-based information on cancer prevention to state-level policy makers. J Natl Cancer Inst 10(4):306–316. https://doi.org/10.1093/jnci/djq529 CrossRef

20.

Hunter DJ (2009) Relationship between evidence and policy: a case of evidence-based policy or policy-based evidence? Public Health 123(9):583–586. https://doi.org/10.1016/j.puhe.2009.07.011 CrossRefPubMed

21.

Macintyre S (2012) Evidence in the development of health policy. Public Health 126(3):217–219. https://doi.org/10.1016/j.puhe.2012.01.026 CrossRefPubMed

22.

Sulik GA, Cameron C, Chamberlain RM (2012) The future of the cancer prevention workforce: why health literacy, advocacy, and stakeholder collaborations matter. J Cancer Educ 27(2 Suppl):S165–172. https://doi.org/10.1007/s13187-012-0337-0 CrossRefPubMed

23.

Kegler MC, Honeycutt S, Davis M, Dauria E, Berg C, Dove C, Gamble A, Hawkins J (2015) Policy, systems, and environmental change in the Mississippi Delta: considerations for evaluation design. Health Educ Behav 42(1 Suppl):57S–66S. https://doi.org/10.1177/1090198114568428 CrossRefPubMed

24.

Fink A (2014) Evaluation fundamentals: insights into program effectiveness, quality, and value. Sage Publications, Thousand Oaks

25.

Gardner AL, Brindis CD (2017) Advocacy and policy change evaluation: theory and practice. Stanford University Press, Stanford

26.

Steele CB, Thomas C, Henley SJ, Massetti G, Galuska D, Agurs Collins T, Puckett M, Richardson L (2017) Vital Signs: trends in incidence of cancers associated with overweight and obesity—United States, 2005–2014. Morb Mortal Wkly Rep 66(39):1052–1058CrossRef

27.

Massetti GM, Dietz WH, Richardson LC (2018) Strategies to prevent obesity-related cancer-reply. JAMA 319(23):2442–2443. https://doi.org/10.1001/jama.2018.4952 CrossRefPubMedPubMedCentral

28.

Puckett M, Neri A, Underwood JM, Stewart SL (2016) Nutrition and Physical activity strategies for cancer prevention in current national comprehensive cancer control program plans. J Commun Health 41(5):1013–1020. https://doi.org/10.1007/s10900-016-0184-8 CrossRef

29.

Preston M, Mays G, Jones RD, Smith S, Stewart C, Henry Tillman R (2014) Reducing cancer disparities through community engagement in policy development: the role of cancer councils. J Health Care Poor Underserved 25(1 Suppl):139–150CrossRefPubMedPubMedCentral

30.

Zahnd WE, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, Colditz GA, Brard L (2017) Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomark Prev. https://doi.org/10.1158/1055-9965.EPI-17-0430 CrossRef

31.

Steele CB, Townsend JS, Courtney-Long EA, Young M (2017) Prevalence of cancer screening among adults with disabilities, United States, 2013. Prev Chronic Dis 14:E09. https://doi.org/10.5888/pcd14.160312 CrossRefPubMedPubMedCentral

32.

Quinn GP, Sanchez JA, Sutton SK, Vadaparampil ST, Nguyen GT, Green BL, Kanetsky PA, Schabath MB (2015) Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin 65(5):384–400. https://doi.org/10.3322/caac.21288 CrossRefPubMedPubMedCentral

33.

Gonzales G, Zinone R (2018) Cancer diagnoses among lesbian, gay, and bisexual adults: results from the 2013–2016 National Health Interview Survey. Cancer Causes Control 29(9):845–854. https://doi.org/10.1007/s10552-018-1060-x CrossRefPubMed

34.

Lisy K, Peters MDJ, Schofield P, Jefford M (2018) Experiences and unmet needs of lesbian, gay, and bisexual people with cancer care: a systematic review and meta-synthesis. Psychooncology 27(6):1480–1489. https://doi.org/10.1002/pon.4674 CrossRefPubMed

35.

Hudson J, Schabath MB, Sanchez J, Sutton S, Simmons VN, Vadaparampil ST, Kanetsky PA, Quinn GP (2017) Sexual and gender minority issues across NCCN guidelines: results from a national survey. J Natl Compr Cancer Netw 15(11):1379–1382. https://doi.org/10.6004/jnccn.2017.0169 CrossRef

36.

Wheldon CW, Schabath MB, Hudson J, Bowman Curci M, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Quinn GP (2018) Culturally competent care for sexual and gender minority patients at National Cancer Institute-Designated Comprehensive Cancer Centers. LGBT Health 5(3):203–211. https://doi.org/10.1089/lgbt.2017.0217 CrossRefPubMedPubMedCentral

37.

Cathcart-Rake EJ (2018) Cancer in sexual and gender minority patients: are we addressing their needs? Curr Oncol Rep 20(11):85. https://doi.org/10.1007/s11912-018-0737-3 CrossRefPubMed

Title: Leveraging the strength of comprehensive cancer control coalitions to support policy, systems, and environmental change
Authors: Angela Moore
Aubrey Villalobos
Annette L. Gardner
Citseko Staples
Sarah Shafir
Publication date: 01-10-2019
Publisher: Springer International Publishing
Keywords: Public Health
Smoking and Nicotine Detoxification
Published in: Cancer Causes & Control / Issue 10/2019
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-019-01215-w

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2019

US urban–rural disparities in breast cancer-screening practices at the national, regional, and state level, 2012–2016

Substitution of dietary protein sources in relation to colorectal cancer risk in the NIH-AARP cohort study

Inflammation and breast density among female Chinese immigrants: exploring variations across neighborhoods

Cancer incidence and associations with known risk and protective factors: the Alaska EARTH study

Low serum cholesterol as a risk factor for kidney and bladder cancer among Korean men: using a national cohort sample

Inherited alterations of TGF beta signaling components in Appalachian cervical cancers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer